Literature DB >> 15526813

Red cell macrocytosis in hypoxemic patients with chronic obstructive pulmonary disease.

Argirios E Tsantes1, Stefanos I Papadhimitriou, Stergios T Tassiopoulos, Stefanos Bonovas, George Paterakis, Ioannis Meletis, Dimitrios Loukopoulos.   

Abstract

Macrocytosis is a common finding in patients with chronic obstructive pulmonary disease (COPD). The cause for the elevation of mean corpuscular volume (MCV) in these patients remains elusive. In an attempt to determine the extent of macrocytosis in COPD patients and search for possible causative factors, we evaluated the hematologic parameters, F-cell percentage, blood gases and serum erythropoietin (Epo) Levels in 32 COPD clinically stable patients and 34 sex- and age-matched non-smoker healthy volunteers. An increased MCV was observed in almost half of the hypoxemic COPD cases (14/32 or 43.75%), while erythrocytosis developed to a lesser degree (37.5%). The erythropoietic response did not correlate with the severity of hypoxia. Moreover, no significant correlation was found between macrocytosis and hypoxemia or erythrocytosis and red cell size. In some cases the two phenomena occurred independently. The F-cell percentage was significantly elevated in the COPD group (P < 0.01) and was associated with MCV values (n = 32, r5 = 0.41, P < 0.05). This finding supports the hypothesis we put forward to explain the macrocytosis often observed in COPD, i.e., that the acute erythropoietic stress occurring repeatedly in these patients as a result of the frequent exacerbations may lead to waves of release of relatively immature, large red cells from the marrow, including an increased number of F-cells, reflecting the recruitment of normally dormant BFU-E (bursts forming units of erythrocyte precursors), which maintain the program for gamma-chain synthesis. The fact that erythrocytosis and macrocytosis, both being triggered by hypoxemia, do not occur consistently in all COPD patients indicates that many other factors may also intervene.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15526813     DOI: 10.1016/j.rmed.2004.04.002

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  5 in total

1.  Influence of a moderate physical activity intervention on red cell deformability in patients suffering from chronic obstructive pulmonary disease (COPD).

Authors:  Basit Ahmad; Nina Ferrari; Georgina Montiel; Wilhelm Bloch; Anke Raabe-Oetker; Nina Skrobala; Klara Brixius
Journal:  Wien Med Wochenschr       Date:  2013-02-20

Review 2.  Anemia in Chronic obstructive pulmonary disease: Prevalence, pathogenesis, and potential impact.

Authors:  Malay Sarkar; Puja Negi Rajta; Jasmin Khatana
Journal:  Lung India       Date:  2015 Mar-Apr

3.  EpoR stimulates rapid cycling and larger red cells during mouse and human erythropoiesis.

Authors:  Daniel Hidalgo; Jacob Bejder; Ramona Pop; Kyle Gellatly; Yung Hwang; S Maxwell Scalf; Anna E Eastman; Jane-Jane Chen; Lihua Julie Zhu; Jules A A C Heuberger; Shangqin Guo; Mark J Koury; Nikolai Baastrup Nordsborg; Merav Socolovsky
Journal:  Nat Commun       Date:  2021-12-17       Impact factor: 14.919

4.  Detection of erythropoietin in exhaled breath condensate of nonhypoxic subjects using a multiplex bead array.

Authors:  Christian Schumann; Kathy Triantafilou; Stefan Krueger; Vinzenz Hombach; Martha Triantafilou; Gunther Becher; Philipp M Lepper
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

5.  Biventricular diastolic dysfunction, thrombocytopenia, and red blood cell macrocytosis in experimental pulmonary arterial hypertension.

Authors:  Ji Young Lee; Karen A Fagan; Chun Zhou; Lynn Batten; Michael V Cohen; Troy Stevens
Journal:  Pulm Circ       Date:  2020-05-26       Impact factor: 3.017

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.